AAAAAA

   
Results: 1-16 |
Results: 16
PHARMACOKINETICS AND PHARMACODYNAMICS OF CETIRIZINE IN INFANTS AND TODDLERS
Authors: SPICAK V DAB I HULHOVEN R DESAGER JP KLANOVA M DELONGUEVILLE M HARVENGT C
Citation: V. Spicak et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CETIRIZINE IN INFANTS AND TODDLERS, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 325-330
PHARMACODYNAMIC ACTIVITY OF LIPOPROTEIN-LIPASE AND HEPATIC LIPASE, AND PHARMACOKINETIC PARAMETERS MEASURED IN NORMOLIPIDEMIC SUBJECTS RECEIVING CIPROFIBRATE (100 OR 200 MG DAY) OR MICRONIZED FENOFIBRATE (200 MG/DAY) THERAPY FOR 23 DAYS/
Authors: DESAGER JP HORSMANS Y VANDENPLAS C HARVENGT C
Citation: Jp. Desager et al., PHARMACODYNAMIC ACTIVITY OF LIPOPROTEIN-LIPASE AND HEPATIC LIPASE, AND PHARMACOKINETIC PARAMETERS MEASURED IN NORMOLIPIDEMIC SUBJECTS RECEIVING CIPROFIBRATE (100 OR 200 MG DAY) OR MICRONIZED FENOFIBRATE (200 MG/DAY) THERAPY FOR 23 DAYS/, Atherosclerosis, 124, 1996, pp. 65-73
PHARMACOKINETICS AND PHARMACODYNAMICS OF CETIRIZINE IN INFANTS
Authors: SPICAK V KLANOVA M HULHOVEN R DESAGER JP DELONGUEVILLE M HARVENGT C
Citation: V. Spicak et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CETIRIZINE IN INFANTS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 197-197
EFFECTS OF GEMFIBROZIL ON PLASMA-LIPOPROTEINS, PLASMA ACTIVITIES OF HEPATIC-ENZYMES, AND HEMOSTATIC VARIABLES IN HYPERTRIGLYCERIDEMIC PATIENTS
Authors: HELLER FR PARFONRY A DESCAMPS O DESAGER JP HARVENGT C
Citation: Fr. Heller et al., EFFECTS OF GEMFIBROZIL ON PLASMA-LIPOPROTEINS, PLASMA ACTIVITIES OF HEPATIC-ENZYMES, AND HEMOSTATIC VARIABLES IN HYPERTRIGLYCERIDEMIC PATIENTS, Current therapeutic research, 56(6), 1995, pp. 597-606
D-PROPOXYPHENE AND NORPROPOXYPHENE KINETICS AFTER THE ORAL-ADMINISTRATION OF D-PROPOXYPHENE - A NEW APPROACH TO LIVER-FUNCTION
Authors: HORSMANS Y DESAGER JP DAENENS C HARVENGT C GEUBEL AP
Citation: Y. Horsmans et al., D-PROPOXYPHENE AND NORPROPOXYPHENE KINETICS AFTER THE ORAL-ADMINISTRATION OF D-PROPOXYPHENE - A NEW APPROACH TO LIVER-FUNCTION, Journal of hepatology, 21(3), 1994, pp. 283-291
DRUGS RECENTLY RELEASED IN BELGIUM - EFLORNITHINE FINASTERIDE
Authors: HARVENGT C
Citation: C. Harvengt, DRUGS RECENTLY RELEASED IN BELGIUM - EFLORNITHINE FINASTERIDE, Acta Clinica Belgica, 49(1), 1994, pp. 42-46
EFFECTS OF SIMVASTATIN AND PRAVASTATIN ON 6-BETA-HYDROXYCORTISOL EXCRETION, A POTENTIAL MARKER OF CYTOCHROME-P-450-3A
Authors: HORSMANS Y DESAGER JP VANDENBERGE V ABRASSART M HARVENGT C
Citation: Y. Horsmans et al., EFFECTS OF SIMVASTATIN AND PRAVASTATIN ON 6-BETA-HYDROXYCORTISOL EXCRETION, A POTENTIAL MARKER OF CYTOCHROME-P-450-3A, Pharmacological research, 28(3), 1993, pp. 243-248
THE EFFECT OF CIMETIDINE ON THE PHARMACOKINETICS OF SINGLE ORAL DOSESOF ALFUZOSIN
Authors: DESAGER JP HARVENGT C BIANCHETTI G ROSENZWEIG P
Citation: Jp. Desager et al., THE EFFECT OF CIMETIDINE ON THE PHARMACOKINETICS OF SINGLE ORAL DOSESOF ALFUZOSIN, International journal of clinical pharmacology, therapy and toxicology, 31(11), 1993, pp. 568-571
SINGLE-DOSE PHARMACOKINETICS OF CETIRIZINE IN PATIENTS WITH CHRONIC LIVER-DISEASE
Authors: HORSMANS Y DESAGER JP HULHOVEN R HARVENGT C
Citation: Y. Horsmans et al., SINGLE-DOSE PHARMACOKINETICS OF CETIRIZINE IN PATIENTS WITH CHRONIC LIVER-DISEASE, Journal of clinical pharmacology, 33(10), 1993, pp. 929-932
SCOPARONE O-DEMETHYLASE ASSAY IS NOT USEFUL TO DIFFERENTIATE THE EFFECTS OF MODEL INDUCERS OF CYTOCHROME-P-450 IN RABBIT AND GUINEA-PIG LIVER
Authors: HORSMANS Y DESAGER JP HARVENGT C
Citation: Y. Horsmans et al., SCOPARONE O-DEMETHYLASE ASSAY IS NOT USEFUL TO DIFFERENTIATE THE EFFECTS OF MODEL INDUCERS OF CYTOCHROME-P-450 IN RABBIT AND GUINEA-PIG LIVER, Life sciences, 53(25), 1993, pp. 421-426
A PHARMACOKINETIC EVALUATION OF THE 2ND-GENERATION H-1-RECEPTOR ANTAGONIST CETIRIZINE IN VERY YOUNG-CHILDREN
Authors: DESAGER JP DAB I HORSMANS Y HARVENGT C
Citation: Jp. Desager et al., A PHARMACOKINETIC EVALUATION OF THE 2ND-GENERATION H-1-RECEPTOR ANTAGONIST CETIRIZINE IN VERY YOUNG-CHILDREN, Clinical pharmacology and therapeutics, 53(4), 1993, pp. 431-435
THE VITAMIN-A FAT-LOADING TEST IN YOUNG NORMOLIPIDEMIC SUBJECTS
Authors: HELLER FR VANDENPLAS C DESAGER JP HARVENGT C
Citation: Fr. Heller et al., THE VITAMIN-A FAT-LOADING TEST IN YOUNG NORMOLIPIDEMIC SUBJECTS, Clinica chimica acta, 219(1-2), 1993, pp. 167-176
EFFECTS OF GEMFIBROZIL ON THE ACTIVITIES OF PLASMA LIPOLYTIC ENZYMES IN NORMOLIPIDEMIC SUBJECTS
Authors: HORSMANS Y DESAGER JP HARVENGT C
Citation: Y. Horsmans et al., EFFECTS OF GEMFIBROZIL ON THE ACTIVITIES OF PLASMA LIPOLYTIC ENZYMES IN NORMOLIPIDEMIC SUBJECTS, Clinica chimica acta, 218(2), 1993, pp. 223-228
COMPARISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN FOR HYPERCHOLESTEROLEMIA
Authors: DAUBRESSE JC DEBACKER G DUCOBU J HARVENGT C DEGENNES JL DOUSTEBLAZY P FARNIER M ANDERS G DAMMANN HG NEUMANN E SCHWARZE B SEIFART C KASTELEIN J STALENHOEF A KEIDAR S CAPURSO A DECESARIS R DESCOVICH G FELLIN R FERUGLIO F MALINI P TRIMARCO B SCOTT R MARAIS A KELLER U MOCCETTI T BLOOMFIELD P CRAMB R HUGHES E SEED M WRAY R STEIN E FRUCHART J SWEANY A SHAPIRO D TATE A
Citation: Jc. Daubresse et al., COMPARISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN FOR HYPERCHOLESTEROLEMIA, The American journal of cardiology, 71(16), 1993, pp. 1408-1414
DRUGS RECENTLY RELEASED IN BELGIUM - CEFPODOXIME PROXETIL-FOSINOPRIL
Authors: HARVENGT C
Citation: C. Harvengt, DRUGS RECENTLY RELEASED IN BELGIUM - CEFPODOXIME PROXETIL-FOSINOPRIL, Acta Clinica Belgica, 48(4), 1993, pp. 284-287
DRUGS RECENTLY RELEASED IN BELGIUM - IBOPAMINE-PRAVASTATIN
Authors: HARVENGT C
Citation: C. Harvengt, DRUGS RECENTLY RELEASED IN BELGIUM - IBOPAMINE-PRAVASTATIN, Acta Clinica Belgica, 48(1), 1993, pp. 54-57
Risultati: 1-16 |